Market Value3,387,005,054
Total Holdings99
File Date2023-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
PTGX / Protagonist Therapeutics, Inc.
HLVX / HilleVax, Inc.
BLI / Berkeley Lights Inc
SLDB / Solid Biosciences Inc.
LIANY / LianBio - Depositary Receipt (Common Stock)
VIR / Vir Biotechnology, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
CINC / CinCor Pharma Inc
CABA / Cabaletta Bio, Inc.
ACRV / Acrivon Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
/ Cytek Biosciences, Inc.
US26886C1154 / EQRx Inc
SLGC / Standard BioTools Inc.
ABOS / Acumen Pharmaceuticals, Inc.
PRVA / Privia Health Group, Inc.
US04685N2027 / ATHENEX INC
US62014P4054 / MOTUS GI HOLDINGS INC
QTRX / Quanterix Corporation
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
IMTX / Immatics N.V.
ACRS / Aclaris Therapeutics, Inc.
AVDL / Avadel Pharmaceuticals plc
CBAY / CymaBay Therapeutics, Inc.
LPTX / Leap Therapeutics, Inc.
KRON / Kronos Bio, Inc.
TERN / Terns Pharmaceuticals, Inc.
NVNO / enVVeno Medical Corporation
PEN / Penumbra, Inc.
IMVT / Immunovant, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF Put
ALDX / Aldeyra Therapeutics, Inc.
BLU / Bellus Health Inc
VRDN / Viridian Therapeutics, Inc.
VKTX / Viking Therapeutics, Inc.
OBIO / Orchestra BioMed Holdings, Inc.
TVTX / Travere Therapeutics, Inc.
SCPH / scPharmaceuticals Inc.
NVRO / Nevro Corp.
ALBO / Albireo Pharma Inc
RLAY / Relay Therapeutics, Inc.
AXGN / Axogen, Inc.
ISEE / IVERIC bio Inc
VRCA / Verrica Pharmaceuticals Inc.
IOVA / Iovance Biotherapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
PRTA / Prothena Corporation plc
HRMY / Harmony Biosciences Holdings, Inc.
ATHA / Athira Pharma, Inc.
TARA / Protara Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
ZYME / Zymeworks Inc.
AORT / Artivion, Inc.
ATXS / Astria Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
RAPT / RAPT Therapeutics, Inc.
COGT / Cogent Biosciences, Inc.
SRPT / Sarepta Therapeutics, Inc.
RVNC / Revance Therapeutics, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
ISO / IsoPlexis Corp
HZNP / Horizon Therapeutics Plc
DICE / DICE Therapeutics Inc
FUSN / Fusion Pharmaceuticals Inc.
ADCT / ADC Therapeutics SA
TMCI / Treace Medical Concepts, Inc.
BLPH / Bellerophon Therapeutics, Inc.
PEAR / Pear Therapeutics Inc - Class A
DRIO / DarioHealth Corp.
NAUT / Nautilus Biotechnology, Inc.
MDGL / Madrigal Pharmaceuticals, Inc. Put
CMAXW / CareMax Inc - Warrants (08/06/2026)
CRNX / Crinetics Pharmaceuticals, Inc.
ACLX / Arcellx, Inc.
LABP / Landos Biopharma, Inc.
BMEA / Biomea Fusion, Inc.
VBIV / VBI Vaccines Inc.
NBTX / Nanobiotix S.A. - Depositary Receipt (Common Stock)
CLOV / Clover Health Investments, Corp.
OM / Outset Medical, Inc.
PNT / POINT Biopharma Global Inc.
LYRA / Lyra Therapeutics, Inc.
CMAX / CareMax, Inc.
SWTX / SpringWorks Therapeutics, Inc.
RXDX / Prometheus Biosciences Inc
BBIO / BridgeBio Pharma, Inc.
OMIC / Singular Genomics Systems, Inc.
VERU / Veru Inc.
PRCT / PROCEPT BioRobotics Corporation
INBX.V / Inhibrx, Inc.
ROIV / Roivant Sciences Ltd.
SRZNW / Surrozen, Inc. - Equity Warrant
XENE / Xenon Pharmaceuticals Inc.
NBIX / Neurocrine Biosciences, Inc.
MGTX / MeiraGTx Holdings plc
APLS / Apellis Pharmaceuticals, Inc.
RETA / Reata Pharmaceuticals Inc - Class A
TARS / Tarsus Pharmaceuticals, Inc.
ATNX / Athenex Inc
ESTA / Establishment Labs Holdings Inc.
ADMA / ADMA Biologics, Inc.
MORF / Morphic Holding, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
NTRA / Natera, Inc.
SAVA / Cassava Sciences, Inc. Put
TYRA / Tyra Biosciences, Inc.
NUVL / Nuvalent, Inc.
XFOR / X4 Pharmaceuticals, Inc.
TCMD / Tactile Systems Technology, Inc.
AKRO / Akero Therapeutics, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
LRMR / Larimar Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.